These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15043758)

  • 1. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
    Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
    BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
    Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
    Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FHIT and TSG101 in thyroid tumours: aberrant transcripts reflect rare abnormal RNA processing events of uncertain pathogenetic or clinical significance.
    McIver B; Grebe SK; Wang L; Hay ID; Yokomizo A; Liu W; Goellner JR; Grant CS; Smith DI; Eberhardt NL
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):749-57. PubMed ID: 10848880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
    Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
    Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.
    Ulivieri A; Lavra L; Dominici R; Giacomelli L; Brunetti E; Sciacca L; Trovato M; Barresi G; Foukakis T; Jia-Jing L; Larsson C; Bartolazzi A; Sciacchitano S
    J Pathol; 2008 May; 215(1):87-96. PubMed ID: 18306168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid.
    Segev DL; Saji M; Phillips GS; Westra WH; Takiyama Y; Piantadosi S; Smallridge RC; Nishiyama RH; Udelsman R; Zeiger MA
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2036-42. PubMed ID: 9626136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic features, proliferative activity, and cyclin D1 expression in Hurthle cell neoplasms of the thyroid.
    Erickson LA; Jin L; Goellner JR; Lohse C; Pankratz VS; Zukerberg LR; Thompson GB; van Heerden JA; Grant CS; Lloyd RV
    Mod Pathol; 2000 Feb; 13(2):186-92. PubMed ID: 10697277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
    Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
    Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-needle aspiration biopsy of Hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis.
    Elliott DD; Pitman MB; Bloom L; Faquin WC
    Cancer; 2006 Apr; 108(2):102-9. PubMed ID: 16453320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiated thyroid carcinomas with vascular invasion: a comparative study of follicular, Hürthle cell and papillary thyroid carcinoma.
    Mai KT; Khanna P; Yazdi HM; Perkins DG; Veinot JP; Thomas J; Lamba M; Nair BD
    Pathology; 2002 Jun; 34(3):239-44. PubMed ID: 12109784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does the fine-needle aspiration diagnosis of "Hürthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy?
    Giorgadze T; Rossi ED; Fadda G; Gupta PK; Livolsi VA; Baloch Z
    Diagn Cytopathol; 2004 Nov; 31(5):307-12. PubMed ID: 15468114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy.
    Máximo V; Lima J; Soares P; Botelho T; Gomes L; Sobrinho-Simões M
    Mitochondrion; 2005 Oct; 5(5):333-40. PubMed ID: 16183030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
    Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C allele of the GNB3 C825T polymorphism of the G protein beta3-subunit is associated with an increased risk for the development of oncocytic thyroid tumours.
    Sheu SY; Handke S; Bröcker-Preuss M; Görges R; Frey UH; Ensinger C; Ofner D; Farid NR; Siffert W; Schmid KW
    J Pathol; 2007 Jan; 211(1):60-6. PubMed ID: 17136758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Follicular and Hurthle cell tumors of the thyroid gland. Possibilities of preoperative differential diagnosis].
    Grineva EN; Goriushkina EV; Malakhova TV; Tsoĭ UA
    Vopr Onkol; 2004; 50(1):41-5. PubMed ID: 15088519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differential diagnosis of oxyphilic (Hürthle cell) adenomas and carcinomas of the thyroid].
    Tret'iakova MS; Bussolati J
    Arkh Patol; 2000; 62(6):14-8. PubMed ID: 11198115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of thyroid Hurthle cells and their neoplasms: the roles of S-100 and HMB-45 proteins.
    Abu-Alfa AK; Straus FH; Montag AG
    Mod Pathol; 1994 Jun; 7(5):529-32. PubMed ID: 7937716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HMGA2 mRNA expression correlates with the malignant phenotype in human thyroid neoplasias.
    Chiappetta G; Ferraro A; Vuttariello E; Monaco M; Galdiero F; De Simone V; Califano D; Pallante P; Botti G; Pezzullo L; Pierantoni GM; Santoro M; Fusco A
    Eur J Cancer; 2008 May; 44(7):1015-21. PubMed ID: 18375116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of Hurthle cell neoplasms by gene profiling.
    Finley DJ; Zhu B; Fahey TJ
    Surgery; 2004 Dec; 136(6):1160-8. PubMed ID: 15657571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular pathogenesis of follicular cell derived thyroid cancers.
    Parameswaran R; Brooks S; Sadler GP
    Int J Surg; 2010; 8(3):186-93. PubMed ID: 20097316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.